Skip to main
WELL

Welltower (WELL) Stock Forecast & Price Target

Welltower (WELL) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 25%
Buy 56%
Hold 19%
Sell 0%
Strong Sell 0%

Bulls say

Welltower is positioned for long-term success due to its diversified healthcare portfolio and its focus on mature healthcare systems such as Canada and the United Kingdom. The company's implementation of the Welltower Business System should drive persistent outperformance with its annual pace of expansion on track for the medium term. The seniors housing backdrop combined with elevated growth and strong operator relationships, along with the implementation of WBS, supports a positive outlook for the company's stock.

Bears say

Welltower is facing significant headwinds in the current market environment due to a potential capital markets tightening, moderating SHOP recovery beyond 2027, as well as the risk of missing underwriting opportunities. Despite a strong start to the year, there is uncertainty surrounding the company's ability to continue driving solid growth and capture attractive investment opportunities in the future. As such, we have a negative outlook on Welltower's stock and believe that its current valuation is too high, considering the potential risks and challenges it may face in the coming years.

Welltower (WELL) has been analyzed by 16 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 56% recommend Buy, 19% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Welltower and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Welltower (WELL) Forecast

Analysts have given Welltower (WELL) a Buy based on their latest research and market trends.

According to 16 analysts, Welltower (WELL) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $237.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $237.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Welltower (WELL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.